ORIGINAL RESEARCH article
Front. Bioinform.
Sec. Drug Discovery in Bioinformatics
Volume 5 - 2025 | doi: 10.3389/fbinf.2025.1565700
INSILICO ANALYSIS OF TRIPHALA-DERIVED POLYPHENOLS AS INHIBITORS OF TIR-TIR HOMODIMERIZATION IN THE INFLAMMATORY PATHWAY
Provisionally accepted- School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The downstream signaling of Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is mediated by the adaptor protein myeloid differentiation primary response gene 88 (MyD88). TIR-domain present in MyD88 plays a pivotal role in regulating the expression of pro-inflammatory cytokines. While synthetic drugs including M20, TJ-M2010-5, etc, were studied to mitigate the over-expression of MyD88, their prolonged usage has been known to cause adverse side reactions, highlighting the need for potential risk-free drug. An Ayurvedic formulation named Triphala, which is rich in polyphenols and traditionally used to treat various ailments was selected for the investigation. Although polyphenols are gaining attention as anti-inflammatory agents, their precise mode of action remains insufficiently understood. Previous studies have explored the anti-inflammatory properties of Triphala in a broad spectrum, but this study notably concentrates on the interactions of Triphala-derived polyphenols against the TIR-domain of MyD88 adaptor protein in the NF-κB signaling pathway. This study employs computational docking and MD simulation to study the interaction and stability of polyphenols with the target protein. The polyphenols were virtually docked with TIR-domain of MyD88 using AutoDock tools 1.5.7. From which top 3 proteinpolyphenol complexes with the highest binding affinities were taken and subjected to MD simulation for 200 ns to evaluate their interaction properties in detail. MD simulation findings corroborated the docking results, in which two complexes (protein-punicalagin and proteinchebulagic acid) have shown better interaction patterns. MD trajectory displays that the polyphenol binding has enhanced the stability of target protein by exhibiting the lower RMSD (~0.25 nm), SASA (~96.848-100.666 nm²), and stabilized Rg (~1.50-1.53 nm) of punicalagin and chebulagic acid complexes when compared to the reference complex. Our findings have supported the hypothesis that Triphala polyphenols can interact with the TIR-domain of MyD88 thereby inhibiting the production of inflammatory cytokines. This study provides a combo of computational validation for specific molecular target and mechanistic insight of Triphala-derived polyphenols into the inhibition of inflammation.
Keywords: nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), Myeloid differentiation primary response gene 88 (MyD88), Triphala, TIR-TIR homo-dimerization, Docking, MD simulation
Received: 23 Jan 2025; Accepted: 25 Apr 2025.
Copyright: © 2025 Rajendran and E. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Nalini E, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.